Meeting
2011 Gastrointestinal Cancers Symposium
Review of completed and ongoing trials of capecitabine-based adjuvant therapy in patients with early-stage colon cancer.
Authors
James Cassidy
University of Glasgow/Beatson West of Scotland Cancer Centre
James Cassidy , Eduardo Diaz-Rubio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 29: 2011 (suppl 4; abstr 495)
Abstract #
495
Poster Bd #
A140
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Effect of oxaliplatin-based adjuvant therapy on post-relapse survival (PRS) in patients with stage III colon cancer: A pooled analysis of individual patient data from four randomized controlled trials.
First Author: Christopher Twelves
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.
First Author: Daniel Walden
Poster
2018 Gastrointestinal Cancers Symposium
Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience.
First Author: Rushabh Kiran Kothari
Poster
2014 Gastrointestinal Cancers Symposium
Cost differential among systemic therapies for colon cancer.
First Author: Hasan Nadeem